Next-Generation
Precision Medicine
to Eradicate Invasive and Metastatic Cancers
WHAT WE DO
PathCision Medicine develops targeted therapies for complex diseases, leveraging tissue pathology insights
OUR VISION
We aim to transform the treatment landscape by paving the path to cure previously incurable diseases, starting with metastatic cancer
OUR FOCUS
Metastatic Cancer
We are developing a next-generation antibody-drug conjugate (ADC) to selectively target metastatic cancer, redefining precision delivery beyond target expression.
OUR PLATFORM
Transforming Cancer Treatment through Computational Pathology
Our platform combines state-of-the-art machine learning with deep biological understanding to revolutionize how we discover and develop new medicines. This has led to the discovery of innovative targets that fuel our innovation pipeline.
